25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Jiangxi Synergy Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyze Jiangxi Synergy Pharmaceutical Co Ltd together

I guess you are interested in Jiangxi Synergy Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Jiangxi Synergy Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Jiangxi Synergy Pharmaceutical Co Ltd

I send you an email if I find something interesting about Jiangxi Synergy Pharmaceutical Co Ltd.

1. Quick Overview

1.1. Quick analysis of Jiangxi Synergy Pharmaceutical Co Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Jiangxi Synergy Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.01
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥5.41
Expected worth in 1 year
¥7.56
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥2.25
Return On Investment
26.9%

For what price can you sell your share?

Current Price per Share
¥8.35
Expected price per share
¥6.85 - ¥11.07
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Jiangxi Synergy Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)
¥8.35
Intrinsic Value Per Share
¥11.53 - ¥13.98
Total Value Per Share
¥16.94 - ¥19.39

2.2. Growth of Jiangxi Synergy Pharmaceutical Co Ltd (5 min.)




Is Jiangxi Synergy Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$320.3m$186.4m$128.3m40.8%

How much money is Jiangxi Synergy Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$4.1m$4m$120.9k2.9%
Net Profit Margin16.2%15.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Jiangxi Synergy Pharmaceutical Co Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Jiangxi Synergy Pharmaceutical Co Ltd?

Welcome investor! Jiangxi Synergy Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Jiangxi Synergy Pharmaceutical Co Ltd.

First you should know what it really means to hold a share of Jiangxi Synergy Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Jiangxi Synergy Pharmaceutical Co Ltd is ¥8.35. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Jiangxi Synergy Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Jiangxi Synergy Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥5.41. Based on the TTM, the Book Value Change Per Share is ¥0.54 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.21 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.03 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Jiangxi Synergy Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.1%0.010.1%0.010.1%0.010.1%0.010.1%
Usd Book Value Change Per Share0.010.1%0.080.9%0.030.4%0.030.3%0.030.4%
Usd Dividend Per Share0.010.1%0.000.0%0.010.1%0.000.0%0.000.0%
Usd Total Gains Per Share0.020.2%0.080.9%0.040.4%0.030.4%0.040.4%
Usd Price Per Share1.43-1.39-1.84-2.90-2.92-
Price to Earnings Ratio41.24-39.12-52.96-130.03-145.57-
Price-to-Total Gains Ratio93.76-65.50-85.71-318.14-309.15-
Price to Book Ratio1.88-1.87-4.17-9.67-10.06-
Price-to-Total Gains Ratio93.76-65.50-85.71-318.14-309.15-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.17234
Number of shares852
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.080.03
Usd Total Gains Per Share0.080.03
Gains per Quarter (852 shares)67.1925.04
Gains per Year (852 shares)268.75100.17
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11225725999190
22451352819181190
33677079728272290
4481027106638363390
5601284133547454490
6721540160457544590
7841797187366635690
8962054214275726790
91082310241185817890
101202567268094907990

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%22.00.00.0100.0%22.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%22.00.00.0100.0%22.00.00.0100.0%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%22.00.00.0100.0%22.00.00.0100.0%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%22.00.00.0100.0%22.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Jiangxi Synergy Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0450.537-92%0.213-79%0.190-76%0.246-82%
Book Value Per Share--5.4145.305+2%3.151+72%2.861+89%2.746+97%
Current Ratio--2.1051.853+14%1.228+71%1.761+20%1.764+19%
Debt To Asset Ratio--0.3150.314+0%0.417-25%0.401-22%0.385-18%
Debt To Equity Ratio--0.4590.458+0%0.717-36%0.704-35%0.666-31%
Dividend Per Share--0.0630.025+150%0.038+65%0.020+220%0.018+243%
Eps--0.0620.070-12%0.063-2%0.052+18%0.050+23%
Free Cash Flow Per Share--0.072-0.008+112%-0.030+143%-0.080+211%-0.085+219%
Free Cash Flow To Equity Per Share--0.072-0.008+112%0.102-30%0.022+219%0.008+850%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--13.978--------
Intrinsic Value_10Y_min--11.527--------
Intrinsic Value_1Y_max--0.031--------
Intrinsic Value_1Y_min--0.029--------
Intrinsic Value_3Y_max--1.136--------
Intrinsic Value_3Y_min--1.064--------
Intrinsic Value_5Y_max--3.501--------
Intrinsic Value_5Y_min--3.160--------
Market Cap3519750516.800-22%4286933149.5004192362356.750+2%5527272892.400-22%8700170364.594-51%8763221183.566-51%
Net Profit Margin--0.1480.162-9%0.150-1%0.145+2%0.144+3%
Operating Margin----0%0.096-100%0.117-100%0.120-100%
Operating Ratio--1.5241.471+4%1.474+3%1.495+2%1.503+1%
Pb Ratio1.542-22%1.8791.873+0%4.166-55%9.674-81%10.062-81%
Pe Ratio33.858-22%41.23839.115+5%52.957-22%130.031-68%145.569-72%
Price Per Share8.350-22%10.1709.918+3%13.113-22%20.634-51%20.784-51%
Price To Free Cash Flow Ratio29.150-22%35.5041434.179-98%-63.262+278%214.795-83%190.785-81%
Price To Total Gains Ratio76.983-22%93.76365.498+43%85.711+9%318.139-71%309.154-70%
Quick Ratio--0.2310.195+18%0.179+29%0.226+2%0.227+2%
Return On Assets--0.0080.009-13%0.013-38%0.012-34%0.012-36%
Return On Equity--0.0110.013-14%0.022-48%0.020-43%0.020-43%
Total Gains Per Share--0.1080.562-81%0.252-57%0.209-48%0.264-59%
Usd Book Value--320387720.099314876508.610+2%186497178.344+72%169508635.015+89%162690915.416+97%
Usd Book Value Change Per Share--0.0060.075-92%0.030-79%0.027-76%0.035-82%
Usd Book Value Per Share--0.7600.745+2%0.442+72%0.402+89%0.386+97%
Usd Dividend Per Share--0.0090.004+150%0.005+65%0.003+220%0.003+243%
Usd Eps--0.0090.010-12%0.009-2%0.007+18%0.007+23%
Usd Free Cash Flow--4238174.677-505648.734+112%-1803464.136+143%-4722910.078+211%-5055060.244+219%
Usd Free Cash Flow Per Share--0.010-0.001+112%-0.004+143%-0.011+211%-0.012+219%
Usd Free Cash Flow To Equity Per Share--0.010-0.001+112%0.014-30%0.003+219%0.001+850%
Usd Market Cap494172972.559-22%601885414.190588607674.888+2%776029114.093-22%1221503919.189-51%1230356254.173-51%
Usd Price Per Share1.172-22%1.4281.392+3%1.841-22%2.897-51%2.918-51%
Usd Profit--3648893.6854159506.084-12%4038599.230-10%3151123.594+16%3035721.845+20%
Usd Revenue--24653764.27725357513.407-3%26875624.449-8%21549092.398+14%20834744.531+18%
Usd Total Gains Per Share--0.0150.079-81%0.035-57%0.029-48%0.037-59%
 EOD+4 -4MRQTTM+17 -17YOY+16 -195Y+23 -1210Y+23 -12

3.3 Fundamental Score

Let's check the fundamental score of Jiangxi Synergy Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1533.858
Price to Book Ratio (EOD)Between0-11.542
Net Profit Margin (MRQ)Greater than00.148
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.231
Current Ratio (MRQ)Greater than12.105
Debt to Asset Ratio (MRQ)Less than10.315
Debt to Equity Ratio (MRQ)Less than10.459
Return on Equity (MRQ)Greater than0.150.011
Return on Assets (MRQ)Greater than0.050.008
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Jiangxi Synergy Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.423
Ma 20Greater thanMa 508.673
Ma 50Greater thanMa 1008.024
Ma 100Greater thanMa 2008.716
OpenGreater thanClose8.450
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Jiangxi Synergy Pharmaceutical Co Ltd

Jiangxi Synergy Pharmaceutical Co., Ltd. manufactures and sells APIs worldwide. It offers raw materials, pharmaceutical intermediates, and fine chemicals. Jiangxi Synergy Pharmaceutical Co., Ltd. was founded in 2004 and is headquartered in Yichun, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-10-12 23:26:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Jiangxi Synergy Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Jiangxi Synergy Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 14.8% means that ¥0.15 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Jiangxi Synergy Pharmaceutical Co Ltd:

  • The MRQ is 14.8%. The company is making a huge profit. +2
  • The TTM is 16.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ14.8%TTM16.2%-1.4%
TTM16.2%YOY15.0%+1.2%
TTM16.2%5Y14.5%+1.7%
5Y14.5%10Y14.4%+0.2%
4.3.1.2. Return on Assets

Shows how efficient Jiangxi Synergy Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Jiangxi Synergy Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.8% Return on Assets means that Jiangxi Synergy Pharmaceutical Co Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Jiangxi Synergy Pharmaceutical Co Ltd:

  • The MRQ is 0.8%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.9%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.8%TTM0.9%-0.1%
TTM0.9%YOY1.3%-0.4%
TTM0.9%5Y1.2%-0.3%
5Y1.2%10Y1.2%0.0%
4.3.1.3. Return on Equity

Shows how efficient Jiangxi Synergy Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Jiangxi Synergy Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.1% Return on Equity means Jiangxi Synergy Pharmaceutical Co Ltd generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Jiangxi Synergy Pharmaceutical Co Ltd:

  • The MRQ is 1.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.3%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.1%TTM1.3%-0.2%
TTM1.3%YOY2.2%-0.9%
TTM1.3%5Y2.0%-0.7%
5Y2.0%10Y2.0%+0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Jiangxi Synergy Pharmaceutical Co Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Jiangxi Synergy Pharmaceutical Co Ltd is operating .

  • Measures how much profit Jiangxi Synergy Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Jiangxi Synergy Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Jiangxi Synergy Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY9.6%-9.6%
TTM-5Y11.7%-11.7%
5Y11.7%10Y12.0%-0.3%
4.3.2.2. Operating Ratio

Measures how efficient Jiangxi Synergy Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.52 means that the operating costs are ¥1.52 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Jiangxi Synergy Pharmaceutical Co Ltd:

  • The MRQ is 1.524. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.471. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.524TTM1.471+0.054
TTM1.471YOY1.474-0.003
TTM1.4715Y1.495-0.024
5Y1.49510Y1.503-0.008
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Jiangxi Synergy Pharmaceutical Co Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Jiangxi Synergy Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.11 means the company has ¥2.11 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Jiangxi Synergy Pharmaceutical Co Ltd:

  • The MRQ is 2.105. The company is able to pay all its short-term debts. +1
  • The TTM is 1.853. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.105TTM1.853+0.253
TTM1.853YOY1.228+0.624
TTM1.8535Y1.761+0.091
5Y1.76110Y1.764-0.002
4.4.3.2. Quick Ratio

Measures if Jiangxi Synergy Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Jiangxi Synergy Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.23 means the company can pay off ¥0.23 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Jiangxi Synergy Pharmaceutical Co Ltd:

  • The MRQ is 0.231. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.195. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.231TTM0.195+0.036
TTM0.195YOY0.179+0.016
TTM0.1955Y0.226-0.031
5Y0.22610Y0.227-0.001
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Jiangxi Synergy Pharmaceutical Co Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Jiangxi Synergy Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Jiangxi Synergy Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.31 means that Jiangxi Synergy Pharmaceutical Co Ltd assets are financed with 31.5% credit (debt) and the remaining percentage (100% - 31.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Jiangxi Synergy Pharmaceutical Co Ltd:

  • The MRQ is 0.315. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.314. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.315TTM0.314+0.001
TTM0.314YOY0.417-0.103
TTM0.3145Y0.401-0.087
5Y0.40110Y0.385+0.016
4.5.4.2. Debt to Equity Ratio

Measures if Jiangxi Synergy Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Jiangxi Synergy Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 45.9% means that company has ¥0.46 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Jiangxi Synergy Pharmaceutical Co Ltd:

  • The MRQ is 0.459. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.458. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.459TTM0.458+0.001
TTM0.458YOY0.717-0.258
TTM0.4585Y0.704-0.245
5Y0.70410Y0.666+0.038
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Jiangxi Synergy Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Jiangxi Synergy Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 41.24 means the investor is paying ¥41.24 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Jiangxi Synergy Pharmaceutical Co Ltd:

  • The EOD is 33.858. Based on the earnings, the company is overpriced. -1
  • The MRQ is 41.238. Based on the earnings, the company is overpriced. -1
  • The TTM is 39.115. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD33.858MRQ41.238-7.380
MRQ41.238TTM39.115+2.122
TTM39.115YOY52.957-13.842
TTM39.1155Y130.031-90.916
5Y130.03110Y145.569-15.538
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Jiangxi Synergy Pharmaceutical Co Ltd:

  • The EOD is 29.150. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 35.504. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 1,434.179. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD29.150MRQ35.504-6.354
MRQ35.504TTM1,434.179-1,398.676
TTM1,434.179YOY-63.262+1,497.441
TTM1,434.1795Y214.795+1,219.384
5Y214.79510Y190.785+24.010
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Jiangxi Synergy Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Jiangxi Synergy Pharmaceutical Co Ltd:

  • The EOD is 1.542. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.879. Based on the equity, the company is underpriced. +1
  • The TTM is 1.873. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.542MRQ1.879-0.336
MRQ1.879TTM1.873+0.005
TTM1.873YOY4.166-2.293
TTM1.8735Y9.674-7.801
5Y9.67410Y10.062-0.388
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,330,034
Total Liabilities1,048,070
Total Stockholder Equity2,281,964
 As reported
Total Liabilities 1,048,070
Total Stockholder Equity+ 2,281,964
Total Assets = 3,330,034

Assets

Total Assets3,330,034
Total Current Assets1,261,158
Long-term Assets2,068,876
Total Current Assets
Cash And Cash Equivalents 421,146
Short-term Investments 30,000
Net Receivables 108,454
Inventory 526,060
Other Current Assets 159,122
Total Current Assets  (as reported)1,261,158
Total Current Assets  (calculated)1,244,782
+/- 16,376
Long-term Assets
Property Plant Equipment 1,516,588
Intangible Assets 19,712
Long-term Assets Other 3,308
Long-term Assets  (as reported)2,068,876
Long-term Assets  (calculated)1,539,607
+/- 529,269

Liabilities & Shareholders' Equity

Total Current Liabilities599,095
Long-term Liabilities448,975
Total Stockholder Equity2,281,964
Total Current Liabilities
Short Long Term Debt 433,656
Accounts payable 107,940
Total Current Liabilities  (as reported)599,095
Total Current Liabilities  (calculated)541,596
+/- 57,499
Long-term Liabilities
Long term Debt 399,000
Capital Lease Obligations Min Short Term Debt1,533
Long-term Liabilities  (as reported)448,975
Long-term Liabilities  (calculated)400,533
+/- 48,442
Total Stockholder Equity
Retained Earnings 548,719
Total Stockholder Equity (as reported)2,281,964
Total Stockholder Equity (calculated)548,719
+/- 1,733,245
Other
Capital Stock421,527
Common Stock Shares Outstanding 421,527
Net Debt 411,510
Net Invested Capital 3,114,620
Net Working Capital 662,063
Property Plant and Equipment Gross 1,516,588



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
835,757
897,073
936,292
1,015,711
1,250,657
1,129,431
1,131,680
1,467,669
1,466,755
1,645,596
1,818,289
1,906,728
1,965,141
2,111,342
2,120,656
2,258,855
2,333,114
2,412,992
3,143,628
3,221,440
3,390,869
3,330,034
3,330,0343,390,8693,221,4403,143,6282,412,9922,333,1142,258,8552,120,6562,111,3421,965,1411,906,7281,818,2891,645,5961,466,7551,467,6691,131,6801,129,4311,250,6571,015,711936,292897,073835,757
   > Total Current Assets 
279,815
307,532
332,369
381,014
609,801
445,182
413,234
665,196
571,265
616,878
663,129
643,557
632,726
725,267
726,752
757,946
691,335
664,824
1,078,659
1,196,984
1,284,774
1,261,158
1,261,1581,284,7741,196,9841,078,659664,824691,335757,946726,752725,267632,726643,557663,129616,878571,265665,196413,234445,182609,801381,014332,369307,532279,815
       Cash And Cash Equivalents 
13,387
16,850
13,960
38,266
237,436
84,895
44,161
280,404
138,985
121,078
188,113
161,291
93,912
149,377
147,555
141,964
84,961
75,020
412,015
512,753
534,775
421,146
421,146534,775512,753412,01575,02084,961141,964147,555149,37793,912161,291188,113121,078138,985280,40444,16184,895237,43638,26613,96016,85013,387
       Short-term Investments 
0
0
0
0
0
0
0
0
1,000
0
0
0
0
0
0
0
0
0
30,000
0
30,000
30,000
30,00030,000030,0000000000001,00000000000
       Net Receivables 
40,946
37,520
24,360
95,399
84,771
72,725
45,105
44,760
65,462
120,005
57,137
95,398
86,545
85,021
93,781
104,708
117,612
99,751
115,810
70,772
118,735
108,454
108,454118,73570,772115,81099,751117,612104,70893,78185,02186,54595,39857,137120,00565,46244,76045,10572,72584,77195,39924,36037,52040,946
       Inventory 
172,220
217,359
255,890
240,127
261,375
277,971
299,710
335,414
339,412
369,503
376,731
373,422
413,004
475,104
471,741
497,358
467,125
474,535
484,727
523,417
494,396
526,060
526,060494,396523,417484,727474,535467,125497,358471,741475,104413,004373,422376,731369,503339,412335,414299,710277,971261,375240,127255,890217,359172,220
       Other Current Assets 
34,147
29,617
31,294
4,719
26,219
7,088
24,259
4,619
26,407
6,278
41,148
13,440
39,266
15,765
13,676
13,803
10,396
6,933
23,916
72,890
78,836
159,122
159,12278,83672,89023,9166,93310,39613,80313,67615,76539,26613,44041,1486,27826,4074,61924,2597,08826,2194,71931,29429,61734,147
   > Long-term Assets 
555,942
589,542
603,923
634,697
640,856
684,249
718,446
802,473
895,490
1,028,718
1,155,160
1,263,171
1,332,415
1,386,074
1,393,903
1,500,909
1,641,779
1,748,167
2,064,969
2,024,456
2,106,094
2,068,876
2,068,8762,106,0942,024,4562,064,9691,748,1671,641,7791,500,9091,393,9031,386,0741,332,4151,263,1711,155,1601,028,718895,490802,473718,446684,249640,856634,697603,923589,542555,942
       Property Plant Equipment 
523,488
550,231
574,370
599,219
601,307
614,461
638,388
754,680
817,360
968,369
1,119,988
1,217,530
1,261,391
1,298,381
1,317,981
1,421,738
1,453,879
1,475,729
1,490,940
1,514,122
1,515,442
1,516,588
1,516,5881,515,4421,514,1221,490,9401,475,7291,453,8791,421,7381,317,9811,298,3811,261,3911,217,5301,119,988968,369817,360754,680638,388614,461601,307599,219574,370550,231523,488
       Intangible Assets 
23,865
2,813
23,367
23,179
22,925
22,715
22,514
22,035
21,844
21,654
21,641
21,435
21,239
21,044
20,848
21,077
20,850
20,622
20,394
20,167
19,939
19,712
19,71219,93920,16720,39420,62220,85021,07720,84821,04421,23921,43521,64121,65421,84422,03522,51422,71522,92523,17923,3672,81323,865
       Long-term Assets Other 
8,379
15,565
6,171
12,175
16,501
46,992
695,816
25,664
56,238
38,602
13,487
24,052
49,650
66,439
54,955
57,964
166,886
251,668
553,489
1,094
2,538
3,308
3,3082,5381,094553,489251,668166,88657,96454,95566,43949,65024,05213,48738,60256,23825,664695,81646,99216,50112,1756,17115,5658,379
> Total Liabilities 
172,443
214,038
237,448
309,403
528,558
392,312
375,801
651,168
630,117
796,623
945,275
1,018,615
1,003,767
1,093,826
865,489
939,187
972,001
1,035,630
952,647
994,991
1,119,422
1,048,070
1,048,0701,119,422994,991952,6471,035,630972,001939,187865,4891,093,8261,003,7671,018,615945,275796,623630,117651,168375,801392,312528,558309,403237,448214,038172,443
   > Total Current Liabilities 
169,789
159,538
171,592
188,066
406,087
274,599
288,937
258,109
209,950
285,595
307,052
360,668
389,108
533,103
524,018
575,036
556,212
688,433
639,033
701,711
672,142
599,095
599,095672,142701,711639,033688,433556,212575,036524,018533,103389,108360,668307,052285,595209,950258,109288,937274,599406,087188,066171,592159,538169,789
       Short-term Debt 
40,000
22,440
50,825
89,306
313,513
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000313,51389,30650,82522,44040,000
       Short Long Term Debt 
40,000
22,440
50,825
89,306
313,513
210,000
246,033
209,371
135,542
136,240
143,766
182,293
147,919
247,936
269,084
267,832
308,841
405,684
373,143
429,312
449,531
433,656
433,656449,531429,312373,143405,684308,841267,832269,084247,936147,919182,293143,766136,240135,542209,371246,033210,000313,51389,30650,82522,44040,000
       Accounts payable 
76,949
85,786
68,656
62,152
67,816
46,833
24,222
30,890
58,121
122,828
139,747
143,783
213,272
195,406
169,119
212,824
163,366
146,172
127,849
130,393
104,682
107,940
107,940104,682130,393127,849146,172163,366212,824169,119195,406213,272143,783139,747122,82858,12130,89024,22246,83367,81662,15268,65685,78676,949
       Other Current Liabilities 
20,000
20,000
20,000
17,797
12,624
4,628
10,915
4,771
8,799
10,710
13,143
11,695
11,180
53,662
51,601
56,328
0
46,894
0
0
0
0
000046,894056,32851,60153,66211,18011,69513,14310,7108,7994,77110,9154,62812,62417,79720,00020,00020,000
   > Long-term Liabilities 
2,654
54,500
65,856
121,337
122,471
117,713
86,864
393,059
420,167
511,029
638,224
657,947
614,659
560,722
341,471
364,151
415,790
347,197
313,615
293,279
447,280
448,975
448,975447,280293,279313,615347,197415,790364,151341,471560,722614,659657,947638,224511,029420,167393,05986,864117,713122,471121,33765,85654,5002,654
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
5,152
5,049
3,789
3,558
3,526
3,053
2,909
2,691
2,473
2,256
2,038
1,810
1,533
1,5331,8102,0382,2562,4732,6912,9093,0533,5263,5583,7895,0495,152000000000
       Other Liabilities 
2,654
7,000
8,356
7,037
11,171
15,413
17,864
27,460
29,293
31,819
34,333
34,524
37,149
34,056
29,418
0
0
38,890
0
0
0
0
000038,8900029,41834,05637,14934,52434,33331,81929,29327,46017,86415,41311,1717,0378,3567,0002,654
> Total Stockholder Equity
663,314
683,036
698,844
706,308
722,099
737,119
755,879
816,501
836,638
848,973
873,014
888,113
961,374
1,017,516
1,255,167
1,319,669
1,361,113
1,377,362
2,190,981
2,226,449
2,271,447
2,281,964
2,281,9642,271,4472,226,4492,190,9811,377,3621,361,1131,319,6691,255,1671,017,516961,374888,113873,014848,973836,638816,501755,879737,119722,099706,308698,844683,036663,314
   Common Stock
80,951
80,951
80,951
80,951
80,387
128,620
128,620
128,620
128,620
205,862
205,864
205,906
209,779
216,390
350,190
0
0
350,265
0
0
0
0
0000350,26500350,190216,390209,779205,906205,864205,862128,620128,620128,620128,62080,38780,95180,95180,95180,951
   Retained Earnings 
188,841
207,839
222,915
250,528
266,319
281,339
300,098
309,651
329,788
341,244
365,262
379,835
406,663
422,473
441,338
416,391
449,488
508,788
479,282
496,028
539,590
548,719
548,719539,590496,028479,282508,788449,488416,391441,338422,473406,663379,835365,262341,244329,788309,651300,098281,339266,319250,528222,915207,839188,841
   Capital Surplus 0000000000000000000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
51,070
51,070
50,919
50,914
50,828
41,086
35,398
0
0
0
0
0
0
0
0
0000000035,39841,08650,82850,91450,91951,07051,0700000000



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue722,139
Cost of Revenue-481,658
Gross Profit240,481240,481
 
Operating Income (+$)
Gross Profit240,481
Operating Expense-599,516
Operating Income122,623-359,035
 
Operating Expense (+$)
Research Development63,151
Selling General Administrative32,137
Selling And Marketing Expenses0
Operating Expense599,51695,289
 
Net Interest Income (+$)
Interest Income17,011
Interest Expense-9,895
Other Finance Cost-752
Net Interest Income6,363
 
Pretax Income (+$)
Operating Income122,623
Net Interest Income6,363
Other Non-Operating Income Expenses0
Income Before Tax (EBT)112,500122,623
EBIT - interestExpense = -9,895
105,983
115,879
Interest Expense9,895
Earnings Before Interest and Taxes (EBIT)0122,396
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax112,500
Tax Provision-6,517
Net Income From Continuing Ops105,983105,983
Net Income105,983
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-6,363
 

Technical Analysis of Jiangxi Synergy Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Jiangxi Synergy Pharmaceutical Co Ltd. The general trend of Jiangxi Synergy Pharmaceutical Co Ltd is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Jiangxi Synergy Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Jiangxi Synergy Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 9.11 < 10.97 < 11.07.

The bearish price targets are: 8.06 > 6.85 > 6.85.

Tweet this
Jiangxi Synergy Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Jiangxi Synergy Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Jiangxi Synergy Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Jiangxi Synergy Pharmaceutical Co Ltd. The current macd is 0.14964466.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Jiangxi Synergy Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Jiangxi Synergy Pharmaceutical Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Jiangxi Synergy Pharmaceutical Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Jiangxi Synergy Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartJiangxi Synergy Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Jiangxi Synergy Pharmaceutical Co Ltd. The current adx is 35.18.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Jiangxi Synergy Pharmaceutical Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Jiangxi Synergy Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Jiangxi Synergy Pharmaceutical Co Ltd. The current sar is 9.77359234.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Jiangxi Synergy Pharmaceutical Co Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Jiangxi Synergy Pharmaceutical Co Ltd. The current rsi is 49.42. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Jiangxi Synergy Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartJiangxi Synergy Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Jiangxi Synergy Pharmaceutical Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Jiangxi Synergy Pharmaceutical Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Jiangxi Synergy Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartJiangxi Synergy Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Jiangxi Synergy Pharmaceutical Co Ltd. The current cci is -70.59908161.

Jiangxi Synergy Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartJiangxi Synergy Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Jiangxi Synergy Pharmaceutical Co Ltd. The current cmo is -7.78277478.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Jiangxi Synergy Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartJiangxi Synergy Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Jiangxi Synergy Pharmaceutical Co Ltd. The current willr is -72.38095238.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Jiangxi Synergy Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Jiangxi Synergy Pharmaceutical Co Ltd Daily Williams %R ChartJiangxi Synergy Pharmaceutical Co Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Jiangxi Synergy Pharmaceutical Co Ltd.

Jiangxi Synergy Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Jiangxi Synergy Pharmaceutical Co Ltd. The current atr is 0.41321662.

Jiangxi Synergy Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartJiangxi Synergy Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Jiangxi Synergy Pharmaceutical Co Ltd. The current obv is 61,060,151.

Jiangxi Synergy Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartJiangxi Synergy Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Jiangxi Synergy Pharmaceutical Co Ltd. The current mfi is 45.51.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Jiangxi Synergy Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartJiangxi Synergy Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Jiangxi Synergy Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-06-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-06-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-07-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-16MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-18MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-04MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-10MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Jiangxi Synergy Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Jiangxi Synergy Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.423
Ma 20Greater thanMa 508.673
Ma 50Greater thanMa 1008.024
Ma 100Greater thanMa 2008.716
OpenGreater thanClose8.450
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Jiangxi Synergy Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Jiangxi Synergy Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Jiangxi Synergy Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Jiangxi Synergy Pharmaceutical Co Ltd

I send you an email if I find something interesting about Jiangxi Synergy Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Jiangxi Synergy Pharmaceutical Co Ltd.

Receive notifications about Jiangxi Synergy Pharmaceutical Co Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.